Literature DB >> 15687922

[Prevalence of Helicobacter pylori in central serous chorioretinopathy and diffuse retinal epitheliopathy: a complementary study].

A Ahnoux-Zabsonre1, M Quaranta, M Mauget-Faÿsse.   

Abstract

INTRODUCTION: In 2001, Mauget-Faysse et al. found a prevalence of Helicobacter pylori infection of 56.3% in 16 patients with central serous chorioretinopathy (CSC) and diffuse retinal epitheliopathy (DRE). This prevalence was twice that of the French population. This complementary study aimed to verify these results. PATIENTS: and method: Between 1996 and 2002, 78 patients living in the southeast of France with CSC/DRE were included in this study. H. pylori infection was assessed by the 13C-urea breath test. Diagnosis was confirmed by fundus biomicroscopy, fluorescein and ICG angiographies and retinal OCT scans (from 2002). Results were analyzed with the Chi2test.
RESULTS: Out of 78 patients, there were 60 males (76.9%) and 18 females (23.1%), with a mean age of 53 years (range, 29-80 years); 27 had CSC (34.6%) and 51 had DRE (65.4%). H. pylori infection was detected as positive in 31 patients (39.7%) and negative in 47 (60.3%). Men were detected positive in 43.3% of cases, compared to women detected positive in only 27.8%. The difference in prevalence of H. pylori between the study population (39.7%) and the overall population of 58,419,710 inhabitants of France in 1999 (25.4%) was found statistically highly significant (p = 0.0036). DISCUSSION: and conclusion: These results may indicate a possible association between H. pylori infection and CSC/DRE manifestations. These data confirm the first results of the 2001 prospective pilot study and also show a higher prevalence of H. pylori infection in men than in women.

Entities:  

Mesh:

Year:  2004        PMID: 15687922     DOI: 10.1016/s0181-5512(04)96281-x

Source DB:  PubMed          Journal:  J Fr Ophtalmol        ISSN: 0181-5512            Impact factor:   0.818


  12 in total

1.  Corticosteroid-associated atypical central serous chorioretinopathy in a patient with multiple sclerosis.

Authors:  Mahmut Kaya; Derya Kaya; Egemen Idiman
Journal:  Int J Ophthalmol       Date:  2017-05-18       Impact factor: 1.779

Review 2.  Central serous chorioretinopathy: update on pathophysiology and treatment.

Authors:  Benjamin Nicholson; Jason Noble; Farzin Forooghian; Catherine Meyerle
Journal:  Surv Ophthalmol       Date:  2013 Mar-Apr       Impact factor: 6.048

Review 3.  Helicobacter pylori as a risk factor for central serous chorioretinopathy: Literature review.

Authors:  Aránzazu Mateo-Montoya; Martine Mauget-Faÿse
Journal:  World J Gastrointest Pathophysiol       Date:  2014-08-15

4.  Clinical efficiency of Helicobacter pylori eradication in the treatment of patients with acute central serous chorioretinopathy.

Authors:  Olesya Zavoloka; Pavlo Bezditko; Irina Lahorzhevska; Darya Zubkova; Yevgeniya Ilyina
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2016-03-16       Impact factor: 3.117

Review 5.  Oral medications for central serous chorioretinopathy: a literature review.

Authors:  William Fusi-Rubiano; Habiba Saedon; Vijay Patel; Yit C Yang
Journal:  Eye (Lond)       Date:  2019-09-16       Impact factor: 3.775

6.  Helicobacter pylori as a potential target for the treatment of central serous chorioretinopathy.

Authors:  Antonio Marcelo Barbante Casella; Rodrigo Fabri Berbel; Gláucio Luciano Bressanim; Marcus Rudolph Malaguido; José Augusto Cardillo
Journal:  Clinics (Sao Paulo)       Date:  2012-09       Impact factor: 2.365

7.  The effect of Helicobacter pylori treatment on remission of idiopathic central serous chorioretinopathy.

Authors:  Mohammad Bagher Rahbani-Nobar; Alireza Javadzadeh; Leila Ghojazadeh; Mandana Rafeey; Amir Ghorbanihaghjo
Journal:  Mol Vis       Date:  2011-01-11       Impact factor: 2.367

8.  Association of Helicobacter pylori with central serous chorioretinopathy in Iranian patients.

Authors:  Mohammad Roshani; Nasrin Ahangar Davoodi; Mohammad Reza Seyyedmajidi; Homayoun Zojaji; Somayeh Jahani Sherafat; Massih Hashemi; Mohammad Reza Zali
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2014

9.  The effect of eradicating Helicobacter pylori on idiopathic central serous chorioretinopathy patients.

Authors:  Yalong Dang; Yalin Mu; Manli Zhao; Lin Li; Yaning Guo; Yu Zhu
Journal:  Ther Clin Risk Manag       Date:  2013-09-02       Impact factor: 2.423

10.  Cadherin 5 is regulated by corticosteroids and associated with central serous chorioretinopathy.

Authors:  Carl Schubert; Anders Pryds; Shemin Zeng; Yajing Xie; K Bailey Freund; Richard F Spaide; John C Merriam; Irene Barbazetto; Jason S Slakter; Stanley Chang; Inger C Munch; Arlene V Drack; Jasmine Hernandez; Suzanne Yzer; Joanna E Merriam; Allan Linneberg; Michael Larsen; Lawrence A Yannuzzi; Robert F Mullins; Rando Allikmets
Journal:  Hum Mutat       Date:  2014-07       Impact factor: 4.700

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.